Literature DB >> 19811947

Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital.

Christelle Vauloup-Fellous1, Olivier Picone, Anne-Gaëlle Cordier, Isabelle Parent-du-Châtelet, Marie-Victoire Senat, René Frydman, Liliane Grangeot-Keros.   

Abstract

BACKGROUND: Cytomegalovirus (CMV) is the most frequent cause of congenital viral infection in developed countries.
OBJECTIVES: The objective of this study was to evaluate the impact of our prenatal CMV infection screening and counseling policy. STUDY
DESIGN: Since 2005, all pregnant women in our obstetric center have been informed about CMV infection, and if they agree, given a serological test at around 12 weeks of gestation (WG). If this first test is negative, the women and their partners are given hygiene counseling on how to prevent CMV infection, and a second test is performed at around 36 WG.
RESULTS: Among the 5312 women who had an unknown immune status, or were known to be seronegative when they had their first visit to our center for their current pregnancy, 97.4% agreed to CMV screening. Primary infection was detected in 11 women between 0 and 12 WG (0.42%), and seroconversion was diagnosed in five women between 12 and 36 WG (0.19%).
CONCLUSIONS: These results suggest that if clear information is given on CMV infection during pregnancy, the rate of seroconversion is lower following counseling than before counseling.

Entities:  

Mesh:

Year:  2009        PMID: 19811947     DOI: 10.1016/j.jcv.2009.09.003

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  60 in total

1.  Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996-2010.

Authors:  Gisela Enders; Anja Daiminger; Lisa Lindemann; Frank Knotek; Ursula Bäder; Simone Exler; Martin Enders
Journal:  Med Microbiol Immunol       Date:  2012-03-08       Impact factor: 3.402

2.  Congenital cytomegalovirus: Impact on child health.

Authors:  Mark R Schleiss
Journal:  Contemp Pediatr       Date:  2018-07

Review 3.  Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection.

Authors:  Michael J Cannon; Terri B Hyde; D Scott Schmid
Journal:  Rev Med Virol       Date:  2011-06-15       Impact factor: 6.989

Review 4.  Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries.

Authors:  Tatiana M Lanzieri; Sheila C Dollard; Stephanie R Bialek; Scott D Grosse
Journal:  Int J Infect Dis       Date:  2014-03-12       Impact factor: 3.623

Review 5.  Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?

Authors:  Michael J Cannon; Paul D Griffiths; Van Aston; William D Rawlinson
Journal:  Rev Med Virol       Date:  2014-04-24       Impact factor: 6.989

Review 6.  Primary Human Cytomegalovirus (HCMV) Infection in Pregnancy.

Authors:  Horst Buxmann; Klaus Hamprecht; Matthias Meyer-Wittkopf; Klaus Friese
Journal:  Dtsch Arztebl Int       Date:  2017-01-27       Impact factor: 5.594

Review 7.  The "silent" global burden of congenital cytomegalovirus.

Authors:  Sheetal Manicklal; Vincent C Emery; Tiziana Lazzarotto; Suresh B Boppana; Ravindra K Gupta
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

8.  Mother-to-Child Transmission of Cytomegalovirus and Prevention of Congenital Infection.

Authors:  Robert F Pass; Brenna Anderson
Journal:  J Pediatric Infect Dis Soc       Date:  2014-09       Impact factor: 3.164

9.  Awareness of and behaviors related to child-to-mother transmission of cytomegalovirus.

Authors:  Michael J Cannon; Kyresa Westbrook; Denise Levis; Mark R Schleiss; Rosemary Thackeray; Robert F Pass
Journal:  Prev Med       Date:  2012-03-21       Impact factor: 4.018

10.  Prevention of maternal cytomegalovirus infection: current status and future prospects.

Authors:  Jessica L Nyholm; Mark R Schleiss
Journal:  Int J Womens Health       Date:  2010-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.